CombiMatrix Corp
Healthcare · Services-Misc Health & Allied Services, NEC · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | |
|---|---|---|---|---|---|---|
| Revenue | $12.9M | $10.1M | $8.0M | $6.4M | $5.3M | $4.7M |
| Operating income | −$4.1M | −$6.5M | −$8.8M | −$6.4M | −$7.0M | −$7.9M |
| Net income | −$4.1M | −$6.6M | −$8.7M | −$3.9M | −$9.5M | −$7.6M |
| Total assets | $8.5M | $7.9M | $8.6M | $16.8M | $5.2M | $9.4M |
| Total liabilities | $2.0M | $2.1M | $1.5M | $2.2M | $5.9M | $1.3M |
| Equity | $6.5M | $5.9M | $7.1M | $14.7M | −$1.1M | $8.2M |
| EPS (diluted) | — | — | — | — | — | — |
| Shares out. | 851,680 | 12.7M | 11.1M | 2.8M | 10.7M | 1.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2016- Operating margin
- −31.8%
- Net margin
- −32.2%
- Return on equity
- −63.8%
- Return on assets
- −48.8%
- Return on capital (ROCE)
- −61.2%
- Liabilities / assets
- 23.4%
- Debt / equity
- 0.31×
- Book value / share
- $7.62
- Revenue growth (YoY)
- 27.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2016- Altman Z″ (distress)
- -34.56distress
- Accruals / assets
- −2.8%clean
- Beneish M-Score
- -2.45normal
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| White LaleDirector | Nov 14, 2017 | D | 835 | — |
| Jones Jeremy MDirector | Nov 14, 2017 | D | 2,001 | — |
| Jessup R JuddDirector | Nov 14, 2017 | D | 2,001 | — |
| Hoffman RobertDirector | Nov 14, 2017 | D | 2,001 | — |
| Burell Scott ROfficer — CFO, Secretary & Treasurer | Nov 14, 2017 | D | 27,368 | — |
| Mcdonough Mark DOfficer — President and CEO | Nov 14, 2017 | D | 89,336 | — |
| Burell Scott ROfficer — CFO, Secretary & Treasurer | Feb 22, 2017 | Sell | 185 | $4.10 |
| Burell Scott ROfficer — CFO, Secretary & Treasurer | Jan 10, 2017 | Sell | 332 | $2.85 |
| Mcdonough Mark DOfficer — President and CEO | Dec 16, 2016 | Grant | 39,402 | $0.00 |
| Burell Scott ROfficer — CFO, Secretary & Treasurer | Dec 16, 2016 | Grant | 19,110 | $0.00 |
| Mcdonough Mark DOfficer — President and CEO | May 10, 2016 | Grant | 31,152 | $0.00 |
| Hoffman RobertDirector | May 10, 2016 | Buy | 5,000 | $3.19 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsNov 15, 2017
- Shareholder vote · Other material eventNov 13, 2017
- Results of operationsNov 6, 2017
- Other material eventNov 1, 2017
- Entered a material agreementSep 27, 2017
- Other material eventSep 25, 2017
- Results of operationsAug 3, 2017
- Entered a material agreement · Other material eventJul 31, 2017
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.